Cargando…
Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma
Elemene is a second-line broad-spectrum anti-tumour drug that has been used in China for more than two decades. However, its main anti-tumour ingredient, β-elemene, has disadvantages, including excessive lipophilicity and relatively weak anti-tumour efficacy. To improve the anti-tumour activity of β...
Autores principales: | Bai, Renren, Zhu, Junlong, Bai, Ziqiang, Mao, Qing, Zhang, Yingqian, Hui, Zi, Luo, Xinyu, Ye, Xiang-Yang, Xie, Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757613/ https://www.ncbi.nlm.nih.gov/pubmed/35012394 http://dx.doi.org/10.1080/14756366.2021.2016734 |
Ejemplares similares
-
Anti-Tumor Drug Discovery Based on Natural Product β-Elemene: Anti-Tumor Mechanisms and Structural Modification
por: Bai, Ziqiang, et al.
Publicado: (2021) -
β-Elemene derivatives produced from SeO(2)-mediated oxidation reaction
por: He, Xingrui, et al.
Publicado: (2020) -
Novel hydroxyl carboximates derived from β-elemene: design, synthesis and anti-tumour activities evaluation
por: Gao, Yuan, et al.
Publicado: (2022) -
β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021) -
Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold
por: Gao, Yuan, et al.
Publicado: (2023)